Open Source Drug Discovery: Finding a Niche (or Maybe Several)

Abstract

Despite their novelty and importance, open source methods have been largely been limited to software. However, scholars have long suggested that it would be logical to organize at least one other field - drug discovery - using open source principles. This paper reviews today's relatively tentative attempts to organize open source biology collaborations and argues that more ambitious projects are feasible. Five specific projects are proposed and analyzed in detail. The article concludes by examining the special legal problems of writing open source licenses in the patent-dominated field of biology.

Keywords: open source biology, open source drug discovery, open source

Paper statistics

Related eJournals

Health Economics Evaluation Methods eJournal

Subscribe to this fee journal for more curated articles on this topic

FOLLOWERS

492

PAPERS

1,686

This Journal is curated by:

Tom Getzen at International Health Economics Association (iHEA), Tor Iversen at University of Oslo, David M. Cutler at Harvard University - Department of Economics, J. Mick Tilford at University of Arkansas for Medical Sciences - Department of Health Policy and Management